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ABSTRACT 
Carbohydrate-aromatic interactions are highly relevant for many biological processes.  
Nevertheless, experimental data in aqueous solution relating structure and energetics for sugar-
arene stacking interactions are very scarce. Here, we evaluate how structural variations in a 
monosaccharide including carboxyl, N-acetyl, fluorine and methyl groups affect stacking 
interactions with aromatic DNA bases. We find small differences on stacking interaction among 
the natural carbohydrates examined. The presence of fluorine atoms within the pyranose ring 
slightly increases the interaction with the C-G DNA base pair. Carbohydrate hydrophobicity is 
the most determinant factor. However, gradual increase in hydrophobicity of the carbohydrate 
does not translate directly into a steady growth in stacking interaction.  The energetics correlates 
better with the amount of apolar surface buried upon sugar stacking on top of the aromatic DNA 
base pair. 
KEYWORDS. Carbohydrates, oligonucleotides, DNA, carbohydrate-DNA interactions, 
carbohydrate-aromatic stacking, hydrophobicity, fluorine 
INTRODUCTION 
Molecular interactions between biomolecules rule most of the biological processes inside 
the cell. A detailed understanding of these interactions provides information on these processes, 
and also allows their exploitation in a variety of applications such as in protein engineering or 
drug design. Stacking between aromatics is among the most studied interactions, whereas full 
comprehension of carbohydrate-aromatic stacking interactions is still to be reached.1 This 
binding-motif is commonly found in carbohydrate-protein interactions such as in lectins2 and is 
also found in aminoglycoside-RNA recognition.3 
Approaches to study carbohydrate–aromatic stacking interactions include molecular 
biology tools,4 NMR spectroscopy,5 IR spectroscopy,6 computational methods,7 and model 
systems based in supramolecular architectures8 or in biomolecules.9 These studies have revealed 
that the hydrophobic effect and CH-p interactions comprising dispersion and electrostatic forces 
play a critical role. A recent work by Chen et al.10 has used an enhanced aromatic sequon 
(sequence of amino acids with an attached oligosaccharide) to study the relative contributions of 
each of these forces. The authors have found that the hydrophobic effect contributes significantly 
to carbohydrate-aromatic stacking and is supplemented by CH-p interactions with a dominating 
dispersive component. 
A model based on carbohydrate oligonucleotide conjugates (COCs) has been employed by 
our group to study carbohydrate-aromatic stacking interactions. We calculated monosaccharide-
phenyl interactions using a double dangling motif at the 5’-end of a self-complementary 
CGCGCG sequence.11 Energies of -0.15 to -0.4 kcal mol-1 were found depending on the 
stereochemistry and number of hydroxyl groups of the sugar. We have also observed mono- and 
disaccharide stacking on top of DNA base pairs in COCs where the sugar is directly linked to the 
5’-end to DNA via an ethylene glycol spacer.12 Extra stabilization of the DNA duplex due to 
sugar stacking was observed on sequences with terminal C-G and G-C base pairs (e.g. up to -0.25 
kcal mol-1 for glucose/DNA unit and -0.45 kcal mol-1 for cellobiose/DNA unit). However, no 
stabilization was found on top of terminal A-T or T-A base pairs most probably due to the 
enhanced entropic cost of reducing the breathing of these more flexible terminal pairs. 
In an effort to increase the energetics of carbohydrate-DNA stacking, we synthesized 
COCs containing hydrophobic versions of natural sugars (permethylated glucose or cellobiose) at 
the edge.13 In this case, the stability of the DNA double helix increased significantly (e.g. up to -
0.8 kcal mol-1 for glc(Me)/DNA unit and -0.9 kcal mol-1 for cellob(Me)/DNA unit). Additionally, 
these apolar carbohydrates were able also to stabilize dsDNA with A–T or T–A terminal base-
pairs. We postulate that CH–p interactions together with the higher hydrophobicity imparted by 
the methyl groups are responsible for duplex stabilization. 
In this work we decided to deepen on understanding carbohydrate-DNA stacking 
interactions by studying three different groups of carbohydrates in our dangling end COC model 
(Figure 1). First, we studied a group of COCs containing natural monosaccharides 5-8 (rhamnose, 
xylose, N-acetylglucosamine and glucuronic acid) to explore the relevance of other 
functionalities on the pyranose. Second, the influence on carbohydrate-DNA stacking of 
increasing hydrophobicity in the pyranose unit was studied with a series of COCs with partially 
hydrophobic glucose units 9-12. We have observed in the NMR structures of permethylated 
glucose-DNA conjugates (Figure 2) that one or two methyl groups apparently do not participate 
contacting the DNA base pair during stacking. The question arising was whether a gradual 
increase in hydrophobicity of the sugar will gradually increase stacking or whether the 
hydrophobic area contacting the aromatic DNA bases will be more determinant. Finally, we 
selected a group of COCs with fluorinated sugars 13-17 in order to study the influence of this 
electron-withdrawing group in the stacking interaction. At the same time, the reduced 
hydrophilicity upon OH®F change could also have a role in the carbohydrate-DNA interactions. 
 
Figure 1. Description of the oligonucleotide conjugates under study. a, Schematic drawing of the 
dangling-ended DNA designed to study carbohydrate-DNA interactions. b, Enlarged view of the 
dangling-end area of a monosaccharide-oligonucleotide conjugate. c, Carbohydrate–
oligonucleotide conjugates included in the study. R= -OCH2CH2-OPO2--CGCGCG. 
 
 Figure 2. Top view of self-complementary DNA conjugates forming a double helix, 
permethylated glucose-CH2CH2-OPO2--CGCGCG (left) and permethylated glucose-CH2CH2-
OPO2—AGCGCT (right). The apolar carbohydrate stacks on top of a C-G base pair (left) and the 
apolar carbohydrate stacks on top of an A-T base pair (right). 
 
RESULTS AND DISCUSSION 
Synthesis of carbohydrate-oligonucleotide conjugates.  
The preparation of carbohydrate-oligonucleotide conjugates was carried out using 
standard solid phase automated oligonucleotide synthesis as reported previously.11-12 Different 
monosaccharides were attached via an ethylene glycol spacer to the 5’-end of the self-
complementary CGCGCG sequence using the corresponding protected carbohydrate 
phosphoramidite derivatives. Their synthesis was carried out by glycosylation of the spacer 
followed by standard phosphoramidite preparation (Scheme 1).   
Scheme 1. Synthesis of rhamnose, xylose, 6-deoxyglucose, N-acetylglucosamine and glucuronate 
methyl ester phophoramidites 20, 23, 26, 31 and 35. 
 
Reagents and conditions: (a) ethylene glycol, Ag2CO3, CH2Cl2; (b) 2-cyanoethyl-N,N’-diisopropyamino-
chlorophosphoramidite, DIPEA, CH2Cl2; (c) 2-benzyloxyethanol, Ag2CO3, CH2Cl2; (d) MeNH2 , THF 
then pyridine/acetic anhydride, DMAP; (e) H2, Pd(OH)2, EtOAc/MeOH (1:1); (f) ethylene glycol, 
BF3.OEt2, CH2Cl2. 
 
In the case of the rhamnose, xylose and 6-deoxyglucose, their sugar phosphoramidites 20, 
23 and 26 were synthesized by attachment of ethylene glycol by Koenigs-Knorr glycosylation 
with the corresponding acetobromosugars.11,14 The promoter used was silver carbonate and the 
isolated yields were between 44 to 83% (Scheme 1). Reaction of the obtained alcohols with 2-
cyanoethyl-N,N’-diisopropylamino-chlorophosphoramidite in the presence of base resulted in the 
carbohydrate phosphoramidite derivatives 20, 23, and 26 in high yields (75-90%). 
The N-acetylglucosamine phosphoramidite 31 was synthesized by glycosylation of 2-
benzyloxyethanol with acetobromo N-phthalimide glucose 27.15 Next, phthalimide deprotection 
with methylamine in THF and acetylation yielded the corresponding N-acetamido derivative 29. 
Finally, hydrogenation of the benzyl protecting group and phosphoramidite incorporation 
produced GlcNAc derivative 33. Glucuronate methyl ester phosphoramidite 35 was synthesized 
from the corresponding trichloroacetimidate glycosyl donor 32.16 When ethylene glycol was used 
as the glycosyl acceptor very low yields of glycosylated product were obtained. Then, 2-
benzyloxyethanol was reacted with 32 to give 33 (30% yield) and subsequent hydrogenation 
resulted in alcohol 33 (46% yield). Synthesis of the corresponding phosphoramidite compound 35 
was carried out as described above. 
 The synthesis of 6-O-acetyl-2,3,4-O-trimethyl glucose phosphoramidite 41 started by 
differentiating the primary hydroxyl group of 2-benzyloxyethyl b-D-glucopyranoside 3613 with a 
TBDPS group (scheme 2). Further methylation of the remaining OH groups, hydrogenation and 
phosphoramidite synthesis yielded derivative 41. In the case of 2,3-O-diacetyl-4,6-O-dimethyl 
glucose phosphoramidite 44 its preparation was carried out from the reported 1,2,3-O-triacetyl-
4,6-O-dimethyl a,b-glucopyranoside 4217 by reaction of its corresponding a-bromo derivative 
with ethylene glycol. Then, hydrogenation and phosphoramidite preparation in similar conditions 
as described above resulted on compound 44. 
Scheme 2. Synthetic route for the preparation of partially methylated glucose phophoramidites 41 
and 44. 
 
Reagents and conditions: (a) TBDPSCl, DIPEA, NEt3, DMF; (b) NaH, MeI, DMF; (c) TBAF 1.0M, 
THF then pyridine/acetic anhydride, DMAP; (d) H2, Pd(OH)2, EtOAc/MeOH (8:1); (e) 2-cyanoethyl-
N,N’-diisopropyamino-chlorophosphoramidite, DIPEA, CH2Cl2; (f) HBr, AcOH, CH2Cl2 then ethylene 
glycol, Ag2CO3, CH2Cl2. 
 
Several mono- and difluorinated carbohydrate phosphoramidite derivatives were 
synthesized from the corresponding acetylated a-bromide compounds (Scheme 3).18 Again 
classical Koenigs-Knorr glycosylation was used and the alcohol derivatives were obtained in 
moderate to good yields (44-78%). The phosphoramidite derivatives of 3-fluoro-3-deoxy-glucose 
47, 4-fluoro-4-deoxy-glucose 50, 6-fluoro-6-deoxy-glucose 53, 4-fluoro-4-deoxy-galactose 56 
and 4,6-difluoro-4,6-dideoxy-galactose 59 were synthesized using the same reaction conditions 
used previously.  
After standard solid phase automated oligonucleotide synthesis, the resulting carbohydrate 
oligonucleotide conjugates were cleaved from the resin after automatic DNA synthesis, 
deprotected with ammonia, HPLC purified and characterized by MALDI-TOF mass spectrometry 
(sup inf). In the case of glucuronic acid DNA conjugate 8, preliminary treatment with Na2CO3 in 
MeOH for 24 h was carried out followed by normal treatment with ammonia and HPLC 
purification. 
 
Scheme 3. Synthetic route for the preparation of fluoro monosaccharide phophoramidites 47, 50, 
53, 56 and 59. 
 
Reagents and conditions: (a) ethylene glycol, Ag2CO3, CH2Cl2; (b) 2-cyanoethyl-N,N’-diisopropyamino-
chlorophosphoramidite, DIPEA, CH2Cl2. 
 
 
Energetics of carbohydrate-DNA interactions.  
 DNA duplex stability was measured by UV-monitored thermal denaturation experiments 
in a pH 7.0 phosphate buffer containing 1 M NaCl. Thermodynamic parameters were calculated 
from melting curve fitting and from van’t Hoff plots (1/Tm versus ln[conjugate]).4a,19 
Thermodynamic parameters for the carbohydrate-oligonucleotide conjugates containing natural 
sugars at the 5’-end 1-8 are shown in Table 1. We observed previously that the presence of 
glucose, galactose and fucose at the edge stabilized the DNA duplex by 3.1-3.5 ºC and by 0.3-0.6 
kcal.mol-1.12 DNA stabilization by xylose and N-acetylglucosamine is in the same range as for the 
previous monosaccharides whereas rhamnose and glucuronic acid are less stabilizing possibly 
due to the presence of an axial OH and a negative charge in the pyranose, respectively. 
 
Table 1. Melting Temperatures and Thermodynamic Parameters for Carbohydrate 
Oligonucleotide Conjugate Duplexes Containing Natural Carbohydrates and the CGCGCG 
Sequence.  
Dangling moiety in                        
5’-CGCGCG a,b,c 
Tm            
(° C) 
-DS°          
(van´t hoff) 
(cal/k · mol) 
-DH°   
(van´t hoff) 
(kcal/mol) 
-DG°37   
(van´t hoff) 
(kcal/mol) 
DG°37    
(fits) 
(kcal/mol) 
DDG°37 d 
(kcal/mol) 
(none)       1 40.9 ± 0.4 114 ± 5 43.5 ± 2 8.2 ± 0.3 8.2 ± 0.1 - 
b-D-glucose-C2 e    2 44.0 ± 0.7 140 ± 4 52.1 ± 2 8.7 ± 0.3 8.7 ± 0.0 -0.5 
b-D-galactose-C2 e    3 44.4 ± 0.4 113 ± 8 43.5 ± 3 8.5 ± 0.5 8.7 ± 0.1 -0.3 
b-L-fucose-C2 e    4 44.4 ± 0.4 136 ± 3 51.1 ± 1 8.8 ± 0.2 8.8 ± 0.0 -0.6 
a-L-rhamnose-C2    5 42.7 ± 0.2 137 ± 7 50.9 ± 2 8.6 ± 0.4 8.5 ± 0.0 -0.4 
b-D-xylose-C2    6 43.6 ± 0.4 156 ± 9 57.2 ± 3 8.8 ± 0.6 8.6 ± 0.1 -0.6 
N-acetyl-b-D-glucosamine-C2    7 44.6 ± 0.3 136 ± 7 50.8 ± 3 8.7 ± 0.5 8.7 ± 0.0 -0.5 
b-D-glucuronic acid-C2    8 42.4 ± 0.7 141 ± 2 52.2 ± 1 8.5 ± 0.1 8.5 ± 0.0 -0.3 
a C2 stands for –CH2-CH2-; b Buffer: 10 mM Na ● phosphate, 1 M NaCl, pH 7.0.; c Average value of three experiments measured at 5 uM conc.; 
d DDG°37 = DGvh – DG (CGCGCG control).e Data from Lucas et al.12  
 
 In the series of hydrophobic glucose DNA conjugates 9-12, all carbohydrates increased 
DNA stability with respect to the natural glucose DNA conjugate 2 (Table 2). Whereas 6-
deoxyglucose showed a small increase in Tm of 0.7 ºC and 0.2 kcal.mol-1 with respect to glucose, 
the other apolar sugar DNA conjugates, 4,6-dimethylated glucose, 2,3,4-trimethylated glucose, 
and 2,3,4,6-tetramethylated glucose derivatives were more stable than 2 by 3.7-4.7 ºC and by 0.7-
0.9 kcal.mol-1. 
Table 2. Melting temperatures and Thermodynamic Parameters for Carbohydrate 
Oligonucleotide Conjugate Duplexes Containing Hydrophobic Sugars and the CGCGCG 
Sequence.  
Dangling moiety in                           
5’-CGCGCG a,b,c 
Tm            
(° C) 
-DS°          
(van´t hoff) 
(cal/k · mol) 
-DH° 
(van´t hoff) 
(kcal/mol)  
-DG°37   
(van´t hoff) 
(kcal/mol) 
DG°37    
(fits) 
(kcal/mol)   
DDG°37 d 
(kcal/mol)   
(none)       1 40.9 ± 0.4 114 ± 5 43.5 ± 2 8.2 ± 0.3 8.2 ± 0.1 - 
b-D-glucose-C2 e    2 44.0 ± 0.7 140 ± 4 52.1 ± 2 8.7 ± 0.3 8.7 ± 0.0 -0.5 
b-D-6-deoxyglucose-C2    9 44.7 ± 0.2 145 ± 5 53.8 ± 2 8.9 ± 0.3 8.8 ± 0.0 -0.7 
b-D-4,6-dimethyl-glc-C2  10 47.7 ± 0.2 157 ± 11 58.3 ± 4 9.6 ± 0.8 9.4 ± 0.1 -1.4 
b-D-2,3,4-trimethyl-glc-C2  11 48.2 ± 0.1 146 ± 11 54.7 ± 4 9.4 ± 0.8 9.4 ± 0.1 -1.2 
b-D-2,3,4,6-tetramethyl-glc-C2f  12    48.7 ± 0.2 147 ± 10 55.1 ± 4 9.4 ± 0.6 9.4 ± 0.1 -1.2 
a C2 stands for –CH2-CH2-; b Buffer: 10 mM Na ● phosphate, 1 M NaCl, pH 7.0.; c Average value of three experiments measured at 5 uM conc.; 
d DDG°37 = DGvh – DG (CGCGCG control).e Data from Lucas et al.12  e Data from Lucas et al.13  
 
It is interesting to observe that the large increase in DNA stability from the dimethylated glucose 
does not correlate with the gradual increase in hydrophobicity in this series as can be deduced 
from the log P values of the glucose derivatives (Table 3). In fact, it does not correlate either with 
the increase in surface area of the apolar sugars. We estimated the actual surface area buried as 
the result of the sugar stacking on top of the C-G final DNA base pair for each of the glucose 
derivatives. A good correlation between the buried surface and the DNA stability is found since 
adding a third and fourth methyl groups to the glucose unit does not increase the stacking area in 
the conjugate but slightly reduces it. This seems to indicate that the free energy of the conjugate 
is also directly related with the number of water molecules displaced by the hydrophobic 
carbohydrates from the area of contact with the DNA base pair and not with the hydrophobicity 
of the carbohydrates. A similar result was found by Kool et al. when studying p-p aromatic 
interactions with nonpolar DNA bases (e.g. benzene, naphthalene, pyrene, etc.) at the edge of 
dsDNA.20  Log P values were a poor predictor of stacking interaction whereas surface area of 
overlap (buried surface by aromatic stacking) was a much better predictor. 
Table 3: Molecular Weight and Partition Coefficient Data for Dangling Moieties Studied.  
Dangling moiety in                           
5’-CGCGCG 
 MW Calc.  
Log Pa 
Surface 
area (Å2)b 
S-area 
folded 
S-area  
unfolded 
Stacking 
area (Å2)c 
glucose 2 194.2 -2.01 186 2918 3093 175 
6-deoxyglucose 9 178.2 -1.16 179 2905 3082 177 
4,6-dimethyl-glucose 10 222.2 -1.29 207 2946 3147 201 
2,3,4-trimethyl-glucose 11 236.3 -0.93 227 2954 3143 189 
2,3,4,6-tetramethyl-
glucose 
12 250.3 -0.57 243 2981 3170 189 
aLog P values were calculated using the Crippen's fragmentation21 in the ChemBioDraw Ultra 
11.0 software. b Half of the calculated surface area of base as Connolly accessible area using 
Chem 3D Pro software. c Estimated as buried surface by substracting the unfolded from the 
folded  carbohydrate-DNA base pair. 
 
 In the series of fluorinated sugars 13-17, DNA stability of the carbohydrate 
oligonucleotide conjugates showed a minor increase with respect to glucose and galactose 
derivatives 2 and 3 (0.3-0.7 ºC in Tm and 0.1-0.2 kcal.mol-1 in DG, see Table 4). The 
incorporation of one or two electron-withdrawing agents such as fluorine atoms in the pyranose 
could modify CH-p interactions between the pyranose ring and the aromatic DNA bases, but this 
effect seems to have little influence in the carbohydrate-aromatic stacking interaction observed. 
These results fit well with those obtained recently by Asensio et al.22  in a dynamic combinatorial 
approach using a disaccharide model system the authors observe a minor strengthening of the 
carbohydrate/aromatic forces by incorporating electron-withdrawing substituents at the anomeric 
position (-F or –CH2CF3).  
 If we consider the relevance of stereochemistry of fluorosugars in the interaction with the 
DNA base pair, for example by comparison of 4-fluoroglucose (4FGlc) and 4-fluorogalactose 
(4FGal), we observe a similar situation to that found when comparing glucose and galactose. 
Possibly, a fluorine atom pointing to the electron-rich p-cloud of the aromatic ring (4FGal) is not 
a favorable scenario in comparison with a partially polarized proton at the same position in 
4FGlc. 
Finally, a couple of explicit comparisons between the three groups of monosaccharides 
may yield some information on the relevance of different modifications in the carbohydrate when 
stacking with DNA bases. If we compare glucose, 6-deoxyglucose and 6-fluoroglucose, we 
observe that replacement of the 6-OH with a proton or a fluorine atom yields only a small 
increase in stability probably due to the small decrease in hydrophilicity with this modification. 
In contrast, a large difference in energetics is observed between 4,6-difluorogalactose and 4,6-
dimethyl-glucose (the latest 1.0 kcal.mol-1 in DG more stable). Bearing in mind the different 
stereochemistry of the carbohydrate, the increased hydrophobic surface in the apolar 
carbohydrate has much more influence in the stacking interaction than increasing the polarity of 
the -CH- protons of the pyranose by the presence of the fluorine atoms. 
 
Table 4. Melting Temperatures and Thermodynamic Parameters for Carbohydrate 
Oligonucleotide Conjugate Duplexes Containing Fluorosugars and the CGCGCG Sequence. 
Dangling moiety in                     
5’-CGCGCG a,b,c 
Tm            
(° C) 
-DS°          
(van´t hoff) 
(cal/k · mol) 
-DH° 
(van´t hoff) 
(kcal/mol) 
-DG°37   
(van´t hoff) 
(kcal/mol) 
DG°37    
(fits) 
(kcal/mol) 
DDG°37 d 
(kcal/mol) 
(none)  1 40.9 ± 0.4 114 ± 5 43.5 ± 2 8.2 ± 0.3 8.2 ± 0.1 - 
b-D-glc-C2   2    44.0 ± 0.7 140 ± 4 52.1 ± 2 8.7 ± 0.3 8.7 ± 0.0 -0.5 
3-F-b-D-glc-C2 13   44.5 ± 0.1 141 ± 2 52.4 ± 1 8.8 ± 0.1 8.8 ± 0.0 -0.6 
4-F-b-D-glc-C2 14   44.7 ± 1.3 141 ± 6 52.5 ± 2 8.9 ± 0.4 8.9 ± 0.1 -0.7 
6-F-b-D-glc-C2 15   44.3 ± 0.0 150 ± 5 55.3 ± 2 8.9 ± 0.3 8.8 ± 0.0 -0.7 
b-D-gal-C2   3     44.4 ± 0.4 113 ± 8 43.6 ± 3 8.5 ± 0.5 8.7 ± 0.1 -0.3 
4-F-b-D-gal-C2 16   44.6 ± 0.9 138 ± 14 51.2 ± 5 8.6 ± 1.0 8.6 ± 0.0 -0.4 
4,6-diF-b-D-gal-C2 17   45.0 ± 0.5 135 ± 9 50.4 ± 3 8.6 ± 0.6 8.6 ± 0.1 -0.4 
a C2 stands for –CH2-CH2-; b Buffer: 10 mM Na ● phosphate, 1 M NaCl, pH 7.0.; c Average value of three experiments measured at 5 uM conc.; 
d DDG°37 = DGvh – DG (CGCGCG control). 
 
Structural features of carbohydrate oligonucleotide conjugates.  
 
As in previous NMR studies in related systems,12-13 no distortion of the DNA double helix 
due to the presence of the fluorinated carbohydrates is observed. Two dimensional NMR spectra 
were recorded for conjugates 13 to 16. Complete resonance assignment was performed and we 
found significant chemical shift differences with the control duplex only for some protons of the 
terminal base pair. Observed NOEs between the sugar units and the terminal C-G base pair were 
very similar to those observed for the corresponding non-fluorinated natural sugars. 
Consequently, we conclude that the structures of the fluorinated conjugates are very similar to 
those previously reported previously, and no further modeling was carried out. 
 
CONCLUSION  
Evaluation of stacking of natural monosaccharides on top of a DNA base pair in water 
using our COC model system have shown small differences due to changes in sugar 
stereochemistry and to the presence of typical functional groups such as N-acetyl or carboxylic 
acid in the pyranose ring. At the same time, replacement of a hydroxyl group with a fluorine atom 
should increase –CH– polarization and local hydrophobicity but none of these aspects showed 
large differences on stacking of the carbohydrate derivatives. Finally, increasing the 
hydrophobicity of the sugars through methylation exhibited a considerable enhancement in 
carbohydrate aromatic stacking. Nevertheless, it is important to emphasize that energetics seem 
to correlate better with the amount of surface contact area between the carbohydrate and the 
aromatic DNA base pair than with a net increase in sugar hydrophobicity. These results appear to 
point out to the relevance of the number of water molecules displaced from the surface of contact 
between the carbohydrate and the aromatics.  
EXPERIMENTAL SECTION 
General methods. All chemicals were obtained from Aldrich Chemicals and used without 
further purification, unless otherwise noted. All reactions were monitored by TLC on precoated 
Silica-Gel 60 plates F254 (Merck), and detected by heating with 5% sulfuric acid in ethanol or 
Mostain (500 ml of 10% H2SO4, 25g of (NH4)6Mo7O24•4H2O, 1g Ce(SO4)2•4H2O). Products 
were purified by flash chromatography with Merck Silica gel 60 (200-400 mesh). High resolution 
FAB (+) and EI (70eV) mass spectra analyses were obtained on a Micromass AutoSpec-Q mass 
spectrometer. ESI mass spectra were obtained on a Esquire 6000 Bruker mass spectrometer. 
NMR spectra were recorded on either a Bruker AVANCE 300 or ARX 400 or Bruker Advance 
DRX 500 MHz [300 or 400 MHz (1H), 75 or 100 (13C)], at room temperature for solutions in 
CDCl3, D2O or CD3OD. Chemical shifts are referred to the solvent signal. 2D experiments 
(COSY, TOCSY, ROESY, and HMQC) were done when necessary to assign the carbohydrate 
derivatives and the conjugates. Chemical shifts are in ppm.  In all experiments the 1H carrier 
frequency was kept at the water resonance.  Data were processed using manufacturer software, 
raw data were multiplied by shifted exponential window function prior to Fourier transform, and 
the baseline was corrected using polynomial fitting. 
Synthetic procedures. General procedure for glycosylation of ethylene glycol. Ag2CO3 (1.7 g, 
6.25 mmol) was added to a solution of the acetyl protected glycosylbromide (2.5 mmol) and 
ethylenglycol (1.3 mL, 25 mmoL) previously dried over molecular sieves, in anhydrous CH2Cl2 
(10 mL).  The reaction was stirred for 24 h, the mixture was then filtered over celite and washed 
with CH2Cl2. The solvent were removed and the crude was purified by flash column 
chromatography (hexane: ethyl acetate mixtures) to afford the corresponding glycosylated 
ethylene glycol. 
2-Hydroxyethyl 2,3,4-tri-O-acetyl-b-L-rhamnopyranose (19). 2,3,4-Tri-O-acetyl-a-L-
rhamnopyranosyl bromide 18 (972 mg, 2.76 mmol) was reacted following the general 
glycosylation procedure. The crude was purified by flash column chromatography (hexane: 
ethyl acetate from 2:1 to 1:2) to afford 19 (592 mg, 64%) as glassy solid; [α]D22 -3.3 (c 1 in 
CHCl3). 1H NMR (300 MHz, CDCl3) δ ppm : 5.26-5.19 (m, 1H, H2), 5.02-4.96 (t, J= 9.8 Hz, 1H, 
H3), 4.72 (s, 1H, H1), 3.90-3.83 (m, 1H, H4), 3.74-3.69 (m, 3H, H5, CH2), 3.51-3.55 (m, 2H, 
CH2), 2.08, 1.99, 1.92 (3s, 9H, 3 x OCOCH3), 1.17-1.15 (d, J= 8 Hz, 3H, CH3); 13C NMR (75 
MHz, CDCl3): δ = 170.1, 170.0, 169.9 (3 x CO), 97.6 (C1), 70.9 (C3), 69.7 (C2), 69.6 (CH2), 
69.10 (C5), 66.4 (C4), 61.3 (CH2), 20.8, 20.7, 20.6 (3 x OCH3), 17.3 (CH3). HRMS (FAB+) Calcd. 
for C14H22O9Na: (M+Na) 357.1162, found; 357.1152. 
2-Hydroxyethyl 2,3,4-tri-O-acetyl-b-D-xylopyranose (22). 2,3,4-Tri-O-acetyl-a-D-xylopyranosyl 
bromide 21 (850 mg, 2.50 mmol) was reacted following the general glycosylation procedure. The 
crude was purified by flash column chromatography (hexane:ethyl acetate from 2:1 to 1:2) to 
afford 22 (540 mg, 66%) as glassy solid; [α]D22 -48.5 (c 1 in CHCl3). 1H NMR (300 MHz, 
CDCl3) δ ppm: 5.18-5.12 (t, J= 9.0 Hz, 1H, H3), 4.97-4.88 (m, 2H, H2, H4), 4.50-4.48 (d, J= 7.2 
Hz, 1H, H1), 4.14-4.08 (dd, J= 5.4/5.1 Hz, 1H, H5), 3.84-3.79 (m, 4H, 2 x CH2), 3.39-3.32 (dd, 
J=5.3 Hz, 1H, H5’), 2.03-2.00 (3s, 9H, 3 x OCOCH3); 13C NMR (75 MHz, CDCl3): δ = 170.4, 
170.3, 169.9 (3 x CO), 100.5 (C1), 72.0 (C3), 71.8 (C2), 71.3 (CH2), 69.1 (C4), 62.5 (CH2), 61.9 
(C5), 21.0. 20.9 (OCCH3). HRMS (FAB+) Calcd. for C13H20O9Na: (M+Na) 343.0999, found; 
343.1005.  
2-Hydroxyethyl 2,3,4-tri-O-acetyl-b-D-6-deoxyglucopyranose (25). 2,3,4-Tri-O-acetyl-6-deoxy-
a-D-glucosylbromide 24 (0.5 g, 1.50 mmol) was reacted following the general glycosylation 
procedure. The crude was purified by flash column chromatography (hexane:ethyl acetate from 
1:1 to 1:2) to afford 25 (196 mg, 44%) as glassy solid; [α]D22 -23.8 (c 1 in CHCl3). 1H NMR (300 
MHz, CDCl3) δ ppm: 5.11 (t, J= 9.0Hz, 1H, H3), 4.92 (dd, J= 9.6 Hz, 1H, H2), 4.77 (t, J= 9.5 Hz, 
1H, H4), 4.46 (d, J= 8.1 Hz, 1H, H1), 3.72-3.69 (m, 2H, CH2), 3.57-3.52 (m, 1H, H5), 2.40 (s, 1H, 
OH), 1.98, 1.97, 1.93 (3 x OCOCH3), 1.18 (d, 3H, J= 6.3 Hz, CH3) ; 13C NMR (75 MHz, CDCl3): 
δ = 170.2, 169.6, 169.5 (CO), 100.9 (C1), 73.2 (C4), 72.7 (C3), 72.1 (CH2), 71.7 (C2), 70.0 (C5), 
61.7 (CH2), 20.7, 20.6, 20.5 (OCCH3), 17.3 (CH3). HRMS (FAB+) Calcd. for C14H22O9Na: 
(M+Na) 357.1162, found; 357.1168. 
2-Benzyloxyethyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-glucopyranose (28). Ag2CO3 
(1.38 g, 5.01 mmol) was added to a solution of 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-
glucopyranosyl bromide 2715 (1 g, 2.0 mmol) and 2-benzyloxyethanol (2.85 mL, 20.0 mmoL) in 
anhydrous CH2Cl2 (12 mL). The reaction was stirred for 16 h and the mixture was then filtered 
over celite and washed with CH2Cl2. The solvent were removed and the crude purified by flash 
column chromatography (hexane:ethyl acetate from 4:1 to 1:1) to afford 28 (800 mg, 70%) as 
glassy solid; [α]D22 +19.7 (c 1 in CHCl3). 1H NMR (300 MHz, CDCl3) δ ppm: 7.74-7.71 (m, 2H, 
Harom, Phth), 7.63-7.59 (m, 2H, Harom, Phth), 7.17-7.00 (m, 5H, Ph), 5.74 (dd, J= 9.0/10.8 Hz, 
1H, H3), 5.39 (d, J= 8.4 Hz, 1H, H1), 5.11 (dd, J= 9.0/10.0 Hz, 1H, H4),  4.32-4.22 (m, 2H, H2, 
H6), 4.17 (s, 2H, CH2Ph), 4.09 (dd, J= 2.4/12.3 Hz, 1H, H6’),  3.92-3.77 (m, 2H, CH2, H5), 3.69-
3.60 (m, 1H, CH2), 3.42-3.39 (m, 2H, CH2), 2.03, 1.95, 1.80 (3s, 9H, 3 x OCOCH3); 13C NMR 
(75 MHz, CDCl3): δ = 170.7, 170.2, 169.5 (3 x CO), 138.0, 134.2,  131.4, 128.4, 128.3, 127.8, 
127.4, 127.3, 123.5, 98.3 (C1), 72.9 (CH2), 71.8 (C5), 70.7 (C3), 69.3 (C4), 69.0, 68.7 (2x CH2), 
62.0 (C6), 54.6 (C2), 20.8. 20.6, 20.5 (OCCH3). HRMS (FAB+) Calcd. for C29H31NO11Na: 
(M+Na) 592.1795, found; 592.1786. 
2-Benzyloxyethyl 3,4,6-tri-O-acetyl-2-acetylamino-2-deoxy-b-D-glucopyranose (29). MeNH2 
(40% aq, 3mL) was added to a solution of 28 (390 mg, 0.68 mmol) in THF (6 mL). The reaction 
was stirred for 16 h. The solvent was then removed and the reaction mixture was co-evaporated 
with dry toluene. The crude was dissolved in dry pyridine (10 mL) and acetic anhydride (3 mL) 
and a catalytic amount of DMAP was added. The reaction mixture was stirred at room 
temperature for 24 h. The solvent was removed in vacuo and the crude was purified by flash 
column chromatography (hexane:ethyl acetate from 1:4 to 0:1) to afford 29 (200 mg, 62% two 
steps) as a brown solid; [α]D22 -24.5 (c 1 in MeOH). 1H NMR (300 MHz, CDCl3) δ ppm: 7.30-
7.19 (m, 5H, Ph), 5.76 (d,  J= 8.7 Hz, 1H, NH), 5.16 (t, J= 9.3 Hz, 1H, H3), 4.99 (t, J= 9.3 Hz, 
1H, H4), 4.69 (d, J= 7.2 Hz, 1H, H1), 4.46 (s, 2H, CH2Ph), 4.21-4.18 (m, 1H, H6), 4.03-3.92 (m, 
1H, H6’), 3.95-3.50 (m, 6H, 2xCH2, H2, H5), 1.99, 1.95, 1.94, 1.78 (3s, 12H, 3 x OCOCH3, N-
COCH3 ); 13C NMR (75 MHz, CDCl3): δ = 170.8, 170.7, 170.3, 169.4 (4 x CO), 138.0, 128.5, 
127.8, 127.6 (Carom), 100.9 (C1), 73.1 (CH2), 72.6 (C3), 71.8 (C5), 69.3 (CH2), 68.8 (C4), 68.6 
(CH2), 62.1 (C6), 54.5 (C2), 23.2 (NCOCH3), 20.8. 20.7, 20.6 (OCCH3). HRMS (FAB+) Calcd. 
for C23H31NO10Na: (M+Na) 504.1846, found; 504.1852. 
2-Hydroxyethyl 3,4,6-tri-O-acetyl-2-acetylamino-2-deoxy-b-D-glucopyranose (30). A solution of 
compound 29 (180 mg, 0.37 mmol) in ethyl acetate-MeOH (1:1, 6 mL) and Pd(OH)2 in catalytic 
amount was stirred under an atmosphere of hydrogen for 48 h. The mixture was filtered off over 
celite and solvents were removed. The crude was purified by silica gel column chromathography 
using as eluent (hexane:ethyl acetate, from 1:4 to 0:1) to give 30 (120 mg, 83%); [α]D22 -2.4 (c 1 
in CHCl3). 1H NMR (400 MHz, CD3OD) δ ppm: 5.22 (t, J= 9.6 Hz, 1H, H3), 5.00  (t, J= 9.6 Hz, 
1H, H4), 4.70 (d, J= 8.4 Hz, 1H, H1), 4.29 (d, J= 4.8/12.4 Hz, 1H, H6), 4.15 (d, J= 2.0/12.4 Hz, 
1H, H6’), 3.91-3.80 (m, 3H, H2, H5, OCH2), 3.70-3.64 (m, 3H, OCH2, CH2OH), 2.08, 2.02, 1.99, 
1.93 (4s, 12H, 3 x OCOCH3, N-COCH3 ); 13C NMR (75 MHz, CDCl3): δ = 172.2, 170.9, 170.4, 
169.9 (4 x CO), 100.8 (C1), 72.8 (C3), 71.5 (C5), 70.9 (CH2O), 68.8 (C4), 61.9 (C6), 60.8 
(CH2OH), 54.1 (C2), 21.4, 19.3, 19.2, 19.1. HRMS (FAB+) Calcd. for C16H25NNaO10Na: (M+Na) 
414.1376, found; 414.1375. 
2-Benzyloxyethyl-(methyl 2,3,4-tri-O-acetyl-b-D-glucopyranosyluronate) (33). BF3.OEt2 (50 ml, 
0.67 mmol) was added to a solution of trichloroacetimidate 3216 (800 mg, 1.67 mmol) and 2-
benzyloxyethanol (356 mL, 2.50 mmol) in anhydrous CH2Cl2 (8 mL). After stirring at room 
temperature for 1 h under argon atmosphere, triethylamine (0.3 mL) was added. Solvents were 
removed and the crude was purified by silica gel column chromatography (toluene:acetone, from 
10:1 to 6:1) to give the 33 (240 mg, 30%) as glassy solid; [α]D22 -20.1 (c 1 in CHCl3). 1H NMR 
(300 MHz, CDCl3) δ ppm: 7.35-7.28 (m, 5H, Ph), 5.27-5.23 (m, 2H, H4, H3), 5.05 (t, J= 8.4 Hz, 
1H, H2), 4.67(d, J= 7.8 Hz, 1H, H1), 4.58-4.50 (m, 2H, CH2Ph), 4.06-3.96 (m, 2H, CH2, H5), 
3.81-3.75 (m, 4H, CH3O, CH2), 3.66-3.63 (m, 2H, CH2), 2.06, 2.03, 199 (3s, 9H, 3 x OCOCH3); 
13C NMR (75 MHz, CDCl3): δ = 170.0, 169.3, 169.2, 167.1 (4 x CO), 137.9 (Cq-arom), 128.3, 
127.5, 127.4 (Carom), 101.9 (C1), 73.1 (CH2), 72.4 (C5), 71.9 (C3), 71.0 (C2), 70.3 (C4), 69.9, 69.3 
(2x CH2), 52.7 (CH3O), 20.5. 20.4 (OCCH3). HRMS (FAB+) Calcd. for C13H20O9Na: (M+Na) 
343.0999, found; 343.1005. 
2-Hydroxyethyl-(methyl 2,3,4-tri-O-acetyl-b-D-glucopyranosyluronate) (34). A solution of 
compound 33 (480 mg, 1.024 mmol) in ethyl acetate-MeOH (1:1, 10 mL) and Pd(OH)2 in 
catalytic amount was stirred under an atmosphere of hydrogen for 18 h. The mixture was filtered 
off over celite and solvents were removed. The crude was purified by silica gel column 
chromathography using as eluent (hexane:ethyl acetate, 1:2) to give 34 (180 mg, 46%) as a syrup; 
[α]D22 -19.0 (c 1 in CHCl3). 1H NMR (500 MHz, CDCl3) δ ppm: 5.31-5.23 (m, 2H, H4, H3), 5.04 
(t, J= 8.0 Hz, 1H, H2), 4.63 (d, J= 7.5 Hz, 1H, H1), 4.10 (d, J= 9.0 Hz, 1H, H5), 3.90-92 (m, 2H, 
CH2), 3.77 (s, 3H, CH3O) 3.76-3.73 (m, 2H, CH2), 2.07, 2.05, 2.04 (3s, 9H, 3 x OCOCH3); 13C 
NMR (125 MHz, CDCl3): δ = 170.1, 169.5, 169.4, 167.1 (4 x CO), 101.2 (C1), 72.9 (C5), 72.3 
(C3), 71.9 (C2), 71.3 (C4), 69.1, 61.9 (2x CH2), 53.0 (CH3O), 20.7, 20.6, 20.5 (OCCH3). HRMS 
(FAB+) Calcd. for C15H22O11Na: (M+Na) 401.1060, found; 401.1060. 
2-Benzyloxyethyl 6-tert-butyldiphenylsilyl-b-D-glucopyranose (37). Dimethylaminopyridine 
(catalytic amount) and triethylamine (0. 476 mL, 4.64 mmoL) were added to a cooled solution of 
2-benzyloxyethyl b-D-glucopyranoside 3613 (1.325 g, 4.22 mmol) in anhydrous DMF under 
argon atmosphere. Then tert-butyldiphenylsilyl chloride (1.21 mL, 4.64 mmoL) was slowly 
added to the mixture and the reaction was left to at room temperature until starting material had 
disappeared in 1h. Ethyl acetate (300 mL) was then added to the mixture and the organic layer 
was washed with brine (2x100 mL), dried with anhydrous Na2SO4 and concentrated to dryness. 
The crude was purified by silica gel column chromatography using ethyl acetate 100% as eluent 
to give 37 (1.3 g, 57%) as a white solid; 1H NMR (400 MHz, CDCl3) δ ppm: 7.63-7.57 (m, 5H, 
Ph), 7.32-7.25 (m, 5H, Ph), 7.23-7.14 (m, 5H, Ph), 4.52-4.35 (m, 2H, CH2), 4.20 (d, J = 7.6 Hz, 
1H, H1) 3.84 (m, 2H, CH2), 3.76 (dd, J = 10.9, 5.3 Hz, 1H), 3.64-3.36 (m, 5H, CH2, H5, H6, H6’),  
3.35-3.25 (m, 2H, H2, H), 0.95 (s, 9H, 3xCH3isopropyl); 13C NMR (101 MHz, CDCl3): δ = 137.7 
(Cq-arom), 135.7 (2xCarom), 135.6 (2xCarom),133.3(Carom), 129.8(2xCarom), 128.5 (2xCarom), 127.9 
(2xCarom), 127.8 (2xCarom), 127.7 (4xCarom), 102.6 (C1), 76.4(CH2), 75.4, 73.4, 73.1, 71.4, 69.0, 
68.3, 64.5 (C2-C5, 2x CH2), 26.8 (3xCH3 iPr), 19.3(CCH3 iPr). HRMS (FAB+) Calcd. for 
C31H40O7Na Si: (M+Na) 575.2441, found; 575.2451. 
2-Benzyloxyethyl 2,3,4-tri-O-methyl-6-tert-butyldiphenylsilyl-b-D-glucopyranose (38). Sodium 
hydride (1.25g, 60% conc., 30.8 mmol) was slowly added to a cooled (0ºC) solution of 2-
benzyloxyethyl 6-O-tert-butyldiphenylsilyl-b-D-glucopyranose (37) (2.13 g, 3.86 mmol) in 
anhydrous DMF (20 mL). After stirring at 0ºC for 10 min under argon atmosphere, methyl iodide 
(3.6 ml, 58 mmol) was added and the reaction was left to process overnight at room temperature. 
The reaction was quenched with 2-propanol and treated with 50mL sat. NH4Cl. The aqueous 
layer was extracted with ethyl acetate (2x 50 ml). The organic layer was then washed with brine 
and Na2S2O3, dried with anhydrous Na2SO4 and concentrated to dryness. The crude was purified 
by silica gel column chromatography (hexane:ethyl acetate, from 4:1 to 2:1) to give 38 (1.5 g, 
67%) as a white solid; 1H NMR (400 MHz, CDCl3) δ ppm: 7.68-7.59 (m, 5H, Ph), 7.33-7.14 (m, 
10H, Ph), 4.49 (s, 2H, CH2), 4.22 (d, J = 7.6 Hz, 1H, H1) 3.95 (m, 1H), 3.79 (d, J = 2.8 Hz, 2H, 
CH2), 3.68-3.59 (m, 3H), 3.55 (s, 3H, OCH3), 3.52 (s, 3H, OCH3), 3.47 (s, 3H, OCH3), 3.27 (t, 
1H,), 3.09 (ddd, J = 8.9, 5.7, 2.8 Hz, 2H), 2.97 (t, 1H, H2), 0.96 (s, 9H, 3xCH3 iPr); 13C NMR 
(101 MHz, CDCl3): δ =, 138.4 (Cq-arom), 135.9 (2xCarom), 135.6 (2xCarom),133.8(Carom), 
133.3(Carom), 129.6(2xCarom), 128.4 (2xCarom), 127.8 (2xCarom), 127.72 (2xCarom), 127.69 
(2xCarom), 127.6 (3xCarom), 103.4 (C1), 86.6, 83.8 (C2), 79.1, 75.6, 73.2, 69.4, 68.7, 62.8, 60.9, 
60.5(2xC), 26.8 (3xCH3 iPr), 19.4(CCH3 iPr). HRMS (FAB+) Calcd. for C34H46O7Na Si: (M+Na) 
617.2911, found; 617.2899. 
2-Benzyloxyethyl 2,3,4-tri-O-methyl-6-O-acetyl-b-D-glucopyranose (39). TBAF (1M in THF, 
4.38ml, 4.38 mmol) was slowly added to a solution of 2-benzyloxyethyl 2,3,4-tri-O-methyl-6-O-
tert-butyldiphenylsilyl-b-D-glucopyranose (38) (1.3 g, 2.19 mmol) in anhydrous THF (10 mL). 
The reaction was stirred for 90 min under argon atmosphere at room temperature. 50 mL of 
CH2Cl2 were added to the reaction mixture and the organic layer was then washed with brine and 
NH4Cl, dried with anhydrous MgSO4 and concentrated to dryness. The crude was purified by 
silica gel column chromatography using as eluent (hexane:ethyl acetate, from 1:2 to 1:4) to give 
2-benzyloxyethyl 2,3,4-tri-O-methyl-b-D-glucopyranose (650 mg, 1.83 mmol, 83%) as a white 
solid. The product was then solved in anhydrous pyridine (10 mL) and acetic anhydride (1.38mL, 
14.6 mmol) and dimethylaminopyridine (catalytic amount) was added to the reaction mixture. 
The reaction was left to process overnight at room temperature under argon atmosphere. CH2Cl2 
was then added to the reaction mixture (50 ml) and the organic layer was washed with brine and 
HCl (5% v/v), dried with anhydrous Na2SO4 and concentrated to dryness. The crude was purified 
by silica gel column chromatography (hexane:ethyl acetate, from 1:1 to 1:3) to give 39 (705 mg, 
97%) as a white solid; 1H NMR (400 MHz, CDCl3) δ ppm: 7.35-7.13 (m, 5H, Ph), 4.48 (s, 2H, 
CH2), 4.26 (d, J = 4.8 Hz, 1H, H1), 4.22 (d, 1H), 4.11 (dd, 1H), 3.99 - 3.86 (m, 1H), 3.66 (dd, 
1H), 3.62 - 3.56 (m, 2H), 3.54 (s, 3H, OCH3), 3.50 (s, 3H, OCH3), 3.48 (s, 3H, OCH3), 3.28 (ddd, 
1H, H5), 3.14 - 2.90 (m, 3H), 1.98 (s, 3H, OCOCH3); 13C NMR (101 MHz, CDCl3): δ = 170.7 
(CO), 138.2 (Cq-arom), 128.3 (2xCarom), 127.6 (2xCarom), 127.55 (Carom), 103.5 (C1), 86.3(CH2), 
83.6, 79.4, 73.1, 72.7, 69.25, 69.05, 63.3 (C2), 60. 8, 60.44, 60.37, 24.7, 20.8(OCOCH3). HRMS 
(FAB+) Calcd. for C20H30O8Na: (M+Na) 421.1838, found; 421.1850. 
2-Hydroxyethyl 2,3,4-tri-O-methyl-6-O-acetyl-b-D-glucopyranose (40). Palladium hydroxyde 
(catalytic amount) was added to a solution of 2-benzyloxyethyl 2,3,4-tri-O-methyl-6-O-acetyl-b-
D-glucopyranose (39) (705 mg, 1.77 mmol) in ethyl acetate (4 mL) and methanol (0.5 mL). The 
reaction was stirred at room temperature under H2 (g) atmosphere (4psi) for 3 h. The mixture was 
then filtered over celite and washed with CH2Cl2 and methanol. The solvents were then removed 
and the crude was purified by flash column chromatography (hexane:ethyl acetate, from 2:1 to 
1:20) to afford 40 (518 mg, 95%) as a white solid; 1H NMR (400 MHz, CDCl3) δ ppm: 4.32 (dd, 
1H, H6´), 4.22 (d, J = 7.8 Hz, 1H, H1), 4.07 (dd, 1H, H6), 3.87 (ddd, 1H), 3.76 (ddd, 1H), 3.70 – 
3.61 (m, 2H), 3.56 (s, 3H, OCH3), 3.53 (s, 3H, OCH3), 3.45 (s, 3H, OCH3), 3.37 (ddd, 1H, H5), 
3.12 (t, 1H, H3), 3.04 - 2.91 (m, 2H, H2, H4), 2.03 (s, 3H, OCOCH3); 13C NMR (101 MHz, 
CDCl3): δ = 170.8 (CO), 104.0 (C1), 86.4(C3), 83.6 (C2), 79.7 (C4), 73.7 (CH2), 72.8 (C5), 63.3 
(C6), 62.4 (CH2), 60.9, 60.7, 60.6 (3x OCH3), 20.7 (OCOCH3). HRMS (FAB+) Calcd. for 
C13H24O8Na: (M+Na) 331.1369, found; 331.1367. 
2-Hydroxyethyl 2,3-di-O-acetyl-4,6-di-O-methyl-b-D-glucopyranose (43). HBr (2 mL, 33% in 
AcOH) were added dropwise to a solution of 1,2,3-tri-O-acetyl-4,6-di-O-methyl-a/b-D-
glucopyranose 4217 (1.0 g, 2.99 mmol) in anhydrous CH2Cl2 (5 mL). The reaction was stirred at 
room temperature for 2 h. The mixture was then washed with ice-water and NaHCO3, dried over 
Na2SO4 and concentrated. 2,3-Di-O-acetyl-4,6-di-O-methyl-b-D-glucopyranose bromide 42b 
(1.06 g) was obtained as a white solid and used without further purification for next step. Ag2CO3 
(2.06 g, 7.48 mmol) was added to a solution of 2,3-di-O-acetyl-4,6-di-O-methyl-b-D-
glucopyranose bromide 42b (1.06 g, 2.99 mmol) and ethylene glycol (167 mL, 2.99 mmol), 
previously dried over molecular sieves, in anhydrous CH2Cl2 (10 mL). The reaction was then 
stirred at room temperature for 16 h under argon atmosphere. The mixture was then filtered over 
celite and washed with CH2Cl2. The solvent was then removed and the crude purified by flash 
column chromatography (hexane:ethyl acetate, from 1:2 to 1:20) to afford 43 (520 mg, 52%) as 
white solid; 1H NMR (400 MHz, CDCl3) δ ppm: 5.15 (t, 1H, H3), 4.90 (t, 1H, H2), 4.48 (d, J= 
7.96 Hz, 1H, H1), 3.89-3.76 (m, 2H, CH2), 3.76-3.55 (m, 4H, CH2, H6, H6’), 3.49 (m, 1H, H5), 
3.43-3.41 (m, 6H, 2 x OCH3), 3.40-3.35 (m, 1H, H4), 2.89 (t, 1H, OH), 2.07-2.04 (m, 6H, 2 x 
OCOCH3); 13C NMR (101 MHz, CDCl3): δ = 170.1, 169.8, (CO), 101.2 (s, C1), 77.6 (s, C4), 74.9 
(s, C3), 74.4 (s, C5), 73.3 (s, CH2), 72.0 (s, C2), 71.0 (s, C6), 62.2 (CH2), 60.3, 59.3 (OCH3), 20.8, 
20.7 (OCOCH3); HRMS (FAB+) Calcd. for C14H24O9: (M+Na) 359.1318, found; 359.1313. 
2-Hydroxyethyl 2,4,6-tri-O-acetyl-3-deoxy-3-fluoro-b-D-glucopyranose (46). 2,4,6-Tri-O-acetyl-
3-deoxy-3-fluoro-a-D-glucopyranosyl bromide 4518d (1.05 g, 2.85 mmol) was reacted following 
the general glycosylation procedure. The crude was purified by flash column chromatography 
(hexane:ethyl acetate, from 1:2 to 1:3) to afford 46 (688 mg, 68%) as a glassy solid; [α]D22 -14.6 
(c 1 in CHCl3). 1H NMR (300 MHz, CDCl3) δ ppm: 5.06-4.93 (m, 2H, H4, H2), 4.37-4.31 (m, 2H, 
H1, H3), 4.06-4.04 (m, 2H, H6, H6’), 3.70-3.52 (m, 5H, 2 x CH2, H5), 2.53 (s, 1H, OH), 1.98, 1.97, 
1.95 (3 x OCOCH3); 13C NMR (75 MHz, CDCl3): δ = 170.9, 169.6, 169.5 (CO), 101.0 (d, JC,F = 
11.1 Hz, C1), 91.8 (d, JC,F = 189.9 Hz, C3), 73.1 (CH2), 71.5 (d, JC,F = 18.7 Hz, C4), 71.2 (d, JC,F 
= 7.65 Hz, C5), 68.6 (d, JC,F = 18.6 Hz, C2), 62.1 (C6), 62.0 (CH2), 20.9, 20.8 (OCCH3); 19F NMR 
(CDCl3, 323.6 MHz): -119.6 ppm. HRMS (FAB+) Calcd. for C14H21O9FNa: (M+Na) 375.1067, 
found; 375.1075.  
2-Hydroxyethyl 2,3,6-tri-O-acetyl-4-deoxy-4-fluoro-b-D-glucopyranose (49). 2,3,6-Tri-O-acetyl-
4-deoxy-4-fluoro-a-D-glucopyranosyl bromide 4818f (2.0 g, 5.00 mmol) was reacted following 
the general glycosylation procedure. The crude was purified by flash column chromatography 
(hexane:ethyl acetate, from 1:2 to 1:4) to afford 49 (1.06 g, 60%) as glassy solid; [α]D22 -12.5 (c 1 
in CHCl3). 1H NMR (300 MHz, CDCl3) δ ppm: 5.03 (dt, JH,F= 15.0, J= 9.0 Hz, 1H, H3), 4.63 (dd, 
J= 7.8/9.6 Hz, 1H, H2), 4.30 (d, J= 7.8 Hz, 1H, H1), 4.26-4.07 (m, 2H, H6, H4), 3.94-3.88 (ddd, 
J= 1.1/5.5/12.2 Hz, 1H, H6’), 3.58-3.47 (m, 4H, 2 x CH2), 3.41-3.38 (m, 1H, H5), 2.43 (br.s, 1H, 
OH), 1.80, 1.75, 1.73 (3 x OCOCH3); 13C NMR (75 MHz, CDCl3): δ = 170.7, 170.1, 169.8 (CO), 
101.3 (C1), 87.0 (d, JC,F = 184.0 Hz, C4), 72.9 (OCH2), 72.6 (d, JC,F = 19.6 Hz, C3), 71.5 (d, JC,F = 
10.05 Hz, C5), 71.3 (d, JC,F = 5.47 Hz, C2), 62.2 (C6), 61.9 (CH2OH), 20.8 (OCCH3); 19F NMR 
(CDCl3, 323.6 MHz): -123.75 ppm. HRMS (FAB+) Calcd. for C14H21O9FNa: (M+Na) 375.1067, 
found; 375.1073. 
2-Hydroxyethyl 2,3,4-tri-O-acetyl-6-deoxy-6-fluoro-b-D-glucopyranose (52). 2,3,4-Tri-O-acetyl-
6-deoxy-6-fluoro-a-D-glucopyranosyl bromide 5118e (742 mg, 2.00 mmol) was reacted following 
the general glycosylation procedure. The crude was purified by flash column chromatography 
(hexane:ethyl acetate, from 1:2 to 1:3) to afford 52 (310 mg, 44%) as glassy solid; [α]D22 -2.2 (c 1 
in CHCl3). 1H NMR (300 MHz, CDCl3) δ ppm: 5.08 (t, J= 9.5 Hz, 1H, H3), 4.90-4.79 (m, 2H, H4, 
H2), 4.44 (d, J= 8.0 Hz, 1H, H1),  4.40-4.22 (dm, JH,F= 47.0 Hz, 2H, H6, H6’), 3.75-3.53 (m, 5H, 2 
x CH2, H5), 2.46 (br.s, 1H, OH), 1.90, 1.88, 1.84 (3 x OCOCH3); 13C NMR (75 MHz, CDCl3): δ 
= 170.0, 169.4, 169.3 (CO), 100.9 (C1), 81.1 (d, JC,F = 174.0 Hz, C6), 72.5 (d, JC,F = 19.3 Hz, C5), 
72.4 (C3), 72.1 (OCH2), 71.1 (C2), 67.8 (d, JC,F = 6.82 Hz, C4), 61.5 (CH2OH), 20.5, 20.4 
(OCCH3); 19F NMR (CDCl3, 323.6 MHz): -155.60 ppm. HRMS (FAB+) Calcd. for 
C14H21O9FNa: (M+Na) 375.1067, found; 375.1071.  
2-Hydroxyethyl 2,3,6-tri-O-acetyl-4-deoxy-4-fluoro-b-D-galactopyranose (55). 2,3,6-Tri-O-
acetyl-4-deoxy-4-fluoro-a-D-galactopyranosyl bromide 5418a,18c (600 mg, 1.62 mmol) was 
reacted following the general glycosylation procedure. The crude was purified by flash column 
chromatography (hexane:ethyl acetate, from 2:3 to 1:3) to afford 55 (447 mg, 78%) as an oil; 1H 
NMR (400 MHz, CDCl3) δ ppm: 5.22 (dd, J = 8.0, 10.4 Hz,1H, H2), 4.94 (ddd, J = 2.4, 10.4, 27.6 
Hz, 1H, H3), 4.81 (dd, J = 2.8, 50 Hz, 1H, H4) , 4.51 (d, J = 7.9 Hz, H1), 4.32-4.20 (m, 2H, H6, 
H6’), 3.89-3.75 (m, 5H, 2 x CH2, H5), 2.74 (s, 1H, OH), 2.04, 2.02, 2.00 (3s, 9H, 3 x OCOCH3); 
13C NMR (100 MHz, CDCl3): δ = 170.5, 170.3, 169.5 (CO), 101.4 (C1), 85.8 (d, JC,F = 185.1 Hz, 
C4), 72.6 (CH2), 71.2 (d, JC,F = 17.6 Hz, C5), 70.9 (d, JC,F = 18.1 Hz, C3), 68.7 (C2), 61.8 (CH2), 
61.5 (d, JC,F = 5.6 Hz, C6), 20.7, 20.6 (OCCH3); 19F NMR (CDCl3, 323.6 MHz, internal reference 
TFT): -216.1 ppm. HRMS (FAB+) Calcd. for C14H21O9FNa: (M+Na) 375.1067, found; 375.1075.  
2-Hydroxyethyl 2,3-di-O-acetyl-4,6-dideoxy-4,6-difluoro-b-D-galactopyranose (58). 2,3-Di-O-
acetyl-4,6-dideoxy-4,6-difluoro-a-D-galactopyranosyl bromide 5718b (253 mg, 0.77 mmol) was 
reacted following the general glycosylation procedure. The crude was purified by flash column 
chromatography (hexane:ethyl acetate, from 1:1 to 1:2) to afford 58 (158 mg, 66%); [α]D22 +5.8 
(c 1 in CHCl3). 1H NMR (400 MHz, CDCl3) δ ppm: 5.20 (t, J= 9.6 Hz, 1H, H2), 5.011-4.79 (m, 
2H, H3, H4),  4.56 (dd, JH,F= 46.4, J= 6.4 Hz, 2H, H6, H6’), 4.55 (d, J= 8.0 Hz, 1H, H1), 3.96-3.83 
(m, 2H, H5, CH), 3.74-3.66 (m, 3H, CH2), 2.72 (br.s, 1H, OH), 2.07, 2.03 (2 x OCOCH3); 13C 
NMR (100 MHz, CDCl3): δ = 170.3, 169.6 (CO), 101.2 (C1), 85.5 (dd, J= 186.0, 5.0 Hz, C4), 
80.4 (dd, J= 170.0, 6.0 Hz, C6), 72.9 (OCH2), 72.1  (CH2), 71.6 (dd, J = 24.0, 18.0 Hz, C5), 71.0 
(d, J = 17.0 Hz, C3), 68.7 (C2), 61.6 (CH2OH), 20.7, 20.6 (OCH3); 19F NMR (CDCl3, 323.6 
MHz): -140.7, -155.1 ppm. MS (ESI+) Calcd. for C12H18O7F2Na: (M+Na) 335.0918, found; 
335.0917. 
 
General procedure for synthesis of carbohydrate phosphoramidites. To a solution of 2-
hydroxyethyl acetyl protected carbohydrate (0.5 mmol) in dry CH2Cl2 (5 mL), DIEA (0.35 mL, 
2.0 mmol) and 2-cyanoethyl-N,N’-diisopropylamino-chlorophosphoramidite (0.174 mL, 0.76 
mmoL) were added at room temperature under argon atmosphere. After 1h the solvent was 
evaporated to dryness. The product was purified by silica gel column chromathography using a 
mixture of hexane, ethyl acetate and triethylamine.  
2-(2,3,4-tri-O-acetyl-b-L-rhamnopyranosyloxy)ethyl (2-cyanoethyl) (N,N-diisopropyl) 
phosphoramidite (20). 2-Hydroxyethyl 2,3,4-tri-O-acetyl-b-L-rhamnopyranose 19 (0.12 g, 0.358 
mmol) was reacted following the general procedure. The crude was purified by flash column 
chromatography (hexane:ethyl acetate, 1:1 with 1% NEt3) to obtain compound 20 as a syrup (165 
mg, 86%); 1H NMR (300 MHz, CDCl3): δ 5.25-5.16 (m, 2H, H2, H3), 4.99 (t, J= 9.9 Hz, 1H, H4), 
4.71 (dd, J= 3.7/1.6 Hz, 1H, H1), 3.94-3.48 (m, 9H, 2xOCH2, OCH2CH2CN, 2xCHisopropyl, H5), 
2.63-2.57 (m, 2H, CH2CN), 2.07, 1.98, 1.91 (3s, 3H, 3 x OCOCH3), 1.19-1.11 (m, 15H, CH3, 
4xCH3isopropyl); 13C NMR (75 MHz, CDCl3): δ = 170.1, 170.0, 169.9 (CO), 117.8 (CN), 97.7 (C1), 
71.1, 69.7, 69.0, 67.8, 67.5, 63.3, 62.4, 62.2, 58.5, 43.2 (NCHisopropyl), 24.6, 24.5 (CH3isopropyl), 
20.9, 20.8 (OCCH3), 20.6 (CH2CN), 17.4 (CH3). HRMS (FAB+) Calcd. for C23H39N2O10PNa: 
(M+Na) 557.2240, found; 557.2222.  
2-(2,3,4-tri-O-acetyl-b-D-xylopyranosyloxy)ethyl (2-cyanoethyl) (N,N-diisopropyl) 
phosphoramidite (23). 2-Hydroxyethyl 2,3,4-tri-O-acetyl-b-D-xylopyranose 22 (0.06 g, 0.197 
mmol) was reacted following the general procedure. The crude was purified by silica gel column 
chromathography (hexane:ethyl acetate, 1:1 with 1% NEt3) to give compound 23 as a syrup (80 
mg, 83%); 1H NMR (300 MHz, CDCl3) δ ppm: 5.08 (t, J= 8.5 Hz, 1H, H3), 4.88-4.82 (m, 2H, H2, 
H4), 4.51 (m, 1H, H1), 4.06 (dd, J= 5.3/11.8Hz, 1H, H5), 3.89-3.46 (m, 8H, 2xOCH2, 
OCH2CH2CN, 2xCHisopropyl), 3.34-3.26 (m, 1H, H5’), 2.61-2.54 (m, 2H, CH2CN), 1.99, 1.98, 1.97 
(3s, 9H, 3 x OCOCH3), 1.11, 1.10 (2d, 12H, 4xCH3isopropyl); 13C NMR (75 MHz, CDCl3): δ = 
170.1, 169.9, 169.4 (3 x CO), 117.7 (CN), 100.7 (C1), 71.4, 70.6, 69.1, 68.8, 62.5, 62.3, 61.9, 
58.5, 58.3, 43.1 (NCHisopropyl), 24.6, 24.5 (CH3isopropyl), 20.8, 20.6 (OCCH3), 20.5 (CH2CN). 
HRMS (FAB+) Calcd. for C22H37KN2O10P: (M+K) 559.1823, found; 559.1827.  
2-(2,3,4,-tri-O-acetyl-6-deoxy-b-D-glucopyranosyloxy)ethyl (2-cyanoethyl) (N,N-diisopropyl) 
phosphoramidite (26). 2-Hydroxyethyl 2,3,4-tri-O-acetyl-6-deoxy-b-D-glucopyranoside 25 
(0.140 g, 0.418 mmol) was reacted following the general procedure. The crude was purified by 
silica gel column chromathography using as eluent (hexane:ethyl acetate, 1:1 with 1% NEt3) to 
give compound 26 as a syrup (200 mg, 90%); 1H NMR (500 MHz, CDCl3): δ 4.90 (t, J= 9.6Hz, 
1H, H3), 4.74-4.680 (m, 1H, H2), 4.57 (t, J= 9.6 Hz, 1H, H4), 4.36 (dd, JH,P= 14.5, J=8.1 Hz, 1H, 
H1), 3.70-3.40 (m, 6H, 2xOCH2, OCH2CH2CN), 3.39-3.29 (m, 3H, 2xCHisopropyl, H5), 2.67-2.62 
(m, 2H, CH2CN), 2.05, 2.03, 1.99 (3s, 3H, 3 x OCOCH3), 1.23 (d, 3H, J= 6.0 Hz, CH3), 1.17 (t, 
12H,  4CH3isopropyl); 13C NMR (75 MHz, CDCl3): δ = 170.2, 169.9, 169.6 (CO), 118.0 (CN), 
100.8 (C1), 73.6 (C4), 73.1 (C3), 71.9 (C2), 70.2 (C5), 69.5, 62.8, 58.7 (3xCH2), 43.3 
(NCHisopropyl), 25.0, 24.9, 24.8, 24.7 (CH3isopropyl), 21.0, 20.9, 20.8 (OCCH3), 20.6 (CH2CN), 17.6 
(CH3). HRMS (FAB+) Calcd. for C23H39N2O10PNa: (M+Na) 557.2240, found; 557.2243.  
2-(3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-b-D-glucopyranosyloxy)ethyl (2-cyanoethyl) (N,N-
diisopropyl) phosphoramidite (31). 2-Hydroxyethyl 3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-b-D-
glucopyranoside 30 (0.20 g, 0.50 mmol) was reacted following the general procedure. The crude 
was purified by silica gel column chromathography (hexane:ethyl acetate, 1:1 with 1% NEt3) to 
give compound 31 as a syrup (265 mg, 90%); 1H NMR (300 MHz, CDCl3): δ 5.92 (dd, J= 3.0/8.7 
Hz, 1H, NH), 4.96 (t, J= 9.6 Hz, 1H, H3), (td, J= 2.7/9.6 Hz, 1H, H4), 4.61 (t, J= 8.4 Hz, 1H, H1), 
3.98 (dd, J= 4.8/12.3 Hz, 1H, H6), 3.84 (dd, J= 2.7/12.3 Hz, 1H, H6’), 3.72-3.40 (m, 9H, 2xOCH2, 
OCH2CH2CN, H2, H5), 3.37-3.26 (m, 2H, 2xCHisopropyl), 2.43-2.39 (m, 2H, CH2CN), 1.81, 1.73, 
1.67 (3s, 12H, 3xOCOCH3), 0.92-0.89 (m, 12H, 4xCH3isopropyl); 13C NMR (75 MHz, CDCl3): δ = 
170.9, 170.6, 169.6 (CO), 118.4 (CN), 101.3 (C1), 73.0 (C3), 72.0 (C4), 69.6, 68.9 (CH2), 62.9 
(CH2), 62.4 (C6), 58.5 (CH2), 54.6 (C2), 43.3 (NCHisopropyl), 24.9 (CH3isopropyl), 21.0, 20.9, 20.8 
(OCCH3), 20.7 (CH2CN). HRMS (FAB+) Calcd. for C25H42N3NaO11P: (M+Na) 614.2455, found: 
614.2440.  
2-(methyl 2,3,4-tri-O-acetyl-b-D-glucopyranosyluronate-oxy)ethyl (2-cyanoethyl) (N,N-
diisopropyl) phosphoramidite (35). 2-Hydroxyethyl methyl 2,3,4-tri-O-acetyl-b-D-
glucopyranosyluronate  34 (0.14 g, 0.37 mmol) was reacted following the general procedure. The 
crude was purified by silica gel column chromathography (hexane:ethyl acetate, 1:1 with 1% 
NEt3) to give compound 35 as a syrup (160 mg, 75%); 1H NMR (300 MHz, CDCl3): δ 5.21-5.11 
(m, 2H, H3, H4), 4.97-4.90 (m, 2H, H2), 4.61 (dd, J= 7.8/9.6 Hz, 1H, H1), 4.00-3.65 (m, 10H, 
2xOCH2, OCH2CH2CN, CH3O, H5), 3.60-3.48 (m, 2H, 2xCHisopropyl), 2.59-2.55 (m, 2H, CH2CN), 
2.04, 1.99 (2s, 9H, 3 xOCOCH3), 1.15-1.09 (m, 12H, 4xCH3isopropyl); 13C NMR (100 MHz, 
CDCl3): δ = 170.1, 169.4, 169.3, 167.2 (4xCO), 117.8 (CN), 100.8 (C1), 72.5 (C5), 72.0 (C3), 71.1 
(C2), 69.6 (CH2), 69.4 (C4), 62.4, 58.5, 52.8 (3xCH2), 43.0 (NCHisopropyl), 24.6, 24.5 (CH3isopropyl), 
20.7, 20.5, 20.4 (OCCH3), 20.3 (CH2CN). HRMS (FAB+) Calcd. for C24H39N2O12PK: (M+K) 
557.1878, found; 557.2188.  
2-(2,3,4-tri-O-methyl-6-O-acetyl-b-D-glucopyranosyloxy)ethyl (2-cyanoethyl) (N,N-diisopropyl) 
phosphoramidite (41). 2-Hydroxyethyl 2,3,4-tri-O-methyl-6-O-acetyl-b-D-glucopyranose 40 
(165 mg, 0.535 mmol) was reacted following the general procedure. The crude was purified by 
silica gel column chromatography (hexane:ethyl acetate, from 3:2 to 1:2 with 1% NEt3) to give 
compound 41 as a white foam (155 mg, 57%); 1H NMR (400 MHz, CDCl3) δ ppm: 4.30 - 4.20 
(m, 2H, H6´, H1), 4.13 (dd, 1H, H6), 3.90 (m, 1H, CH2), 3.85 - 3.73 (m, 3H, CH iPr, CH2 ), 3.67 
(dtt, 2H, CH2), 3.55 (s, 5H, OCH3+2H), 3.51 (s, 3H, OCH3), 3.44 (s, 3H, OCH3), 3.30 (ddd, 1H, 
H5), 3.10 (t, 1H, H3), 3.02 (t, 1H, H4), 2.92 (ddd, 1H, H2), 2.58 (t, 2H, CH2), 2.02 (s, 3H, 
OCOCH3), 1.14-1.08 (m, 12H, 4xCH3 isopropyl); 13C NMR (101 MHz, CDCl3): δ = 170.8 (CO) , 
117.7 (CN), 103.5 (C1), 86.3, 83.6, 79.4, 72.7 , 69.6 (dd), 63.3 , 62.4 (dd), 60.8, 60.6 - 60.2 (m, 
2C), 58.4 (dd), 43.0 (dd, 2C), 24.7 - 24.4 (m, 4C), 20.8, 20.3; HRMS (FAB+) Calcd. for 
C22H41N2O9PK: (M+K) 547.2187, found; 547.2474. 
2-(2,3-di-O-acetyl-4,6-di-O-methyl-b-D-glucopyranosyloxy)ethyl (2-cyanoethyl) (N,N-
diisopropyl) phosphoramidite (44). 2-Hydroxyethyl 2,3-di-O-acetyl-4,6-di-O-methyl-b-D-
glucopyranose 43 (0.150 g, 0.45 mmol) was reacted following the general procedure. The crude 
was purified by silica gel column chromathography (hexane:ethyl acetate, 1:1 with 1% NEt3) to 
give compound 44 as a white foam (111 mg, 53%); 1H NMR (400 MHz, CDCl3) δ ppm: 5.14 (m, 
1H, H3), 4.89 (ddd, 1H, H2), 4.55 (dd, 1H, H1), 3.98 (m, 2H, CH2), 3.83 (m, 2H, CH2), 3.73 (m, 
2H, CH2), 3.68-3.56 (m, 5H, H5, H6/H6´, 2x CHisopropyl), 3.48-3.40 (m, 7H, H4, 2xOCH3), 2.66 
(m, 2H, CH2), 2.06 (m, 6H, 2xOCOCH3), 1.19 (m, 12H, 4xCH3isopropyl); 13C NMR (101 MHz, 
CDCl3): δ = 170.2, 169.7 (CO), 117.8 (CN), 100.7 (C1), 75.1, 74.7, 71.9, 70.8, 69.3, 69.1, 62.5, 
62.3, 60.3, 59.4, 58.6, 58.4, 43.1, 43.0, 24.7, 24.6, 24.5, 20.8, 20.4; MS (ESI+) Calcd. for 
C23H41N2O10KP: (M+K) 575.2136, found; 575.2307. 
2-(2,4,6-tri-O-acetyl-3-deoxy-3-fluoro-b-D-glucopyranosyloxy)ethyl (2-cyanoethyl) (N,N-
diisopropyl) phosphoramidite (47). 2-Hydroxyethyl 2,4,6-tri-O-acetyl-3-deoxy-3-fluoro-b-D-
glucopyranose 46 (0.220 g, 0.62 mmol) was reacted following the general procedure. The crude 
was purified by silica gel column chromathography (hexane:ethyl acetate, from 3:2 to 1:1 with 
1% NEt3) to give compound 47 as a syrup (260 mg, 76%); 1H NMR (300 MHz, CDCl3) δ ppm: 
5.11-4.91 (m, 2H, H4, H2), 4.53-4.28 (m, 2H, H1, H3), 4.12 (ddd, J= 2.0/4.7/12.4 Hz, 1H, H6),  
3.99 (br. d, J= 12.3 Hz, 1H, H6’), 3.86-3.53 (m, 6H, 2xOCH2, OCH2CH2CN)  3.52-3.40 (m, 3H, 
2xCHisopropyl, H5), 2.53-2.49 (m, 2H, CH2CN), 1.99, 1.97, 1.96 (s, 9H, 3xOCOCH3), 1.05, 1.03 
(2d, 12H,  4CH3isopropyl); 13C NMR (75 MHz, CDCl3): δ = 170.9, 169.5, 169.4 (CO), 118.0 (CN), 
101.0 (d, JC,F = 10.65 Hz, C1), 91.9 (d, JC,F = 189.1 Hz, C3), 71.4 (d, JC,F = 18.5 Hz, C2), 71.1 (d, 
JC,F = 7.65 Hz, C5), 69.8 (CH2), 68.5 (d, JC,F = 18.3 Hz, C4), 62.6 (CH2), 62.0 (C6), 58.6 (CH2), 
43.3 (NCHisopropyl), 24.9, 24.8 (CH3 isopropyl), 21.1, 21.0, 20.9 (OCCH3), 20.6 (CH2CN). HRMS 
(FAB+) Calcd. for C23H38N2O10FNaP: (M+Na) 575.2146, found; 575.2158. 
2-(2,3,6-tri-O-acetyl-4-deoxy-4-fluoro-b-D-glucopyranosyloxy)ethyl (2-cyanoethyl) (N,N-
diisopropyl) phosphoramidite (50). 2-Hydroxyethyl 2,3,6-tri-O-acetyl-4-deoxy-4-fluoro-b-D-
glucopyranose 49 (0.365 g, 1.036 mmol) was reacted following the general procedure. The crude 
was purified by silica gel column chromathography (hexane:ethyl acetate, from 3:2 to 1:1 with 
1% NEt3) to give compound 50 as a syrup (434 mg, 76%); 1H NMR (300 MHz, CDCl3) δ ppm: 
5.03 (dt, JH,F= 15.0, J= 9.0 Hz, 1H, H3), 4.68 (dd, J= 7.8/9.6 Hz, 1H, H2), 4.40 (dd, J= 7.8/10.5 
Hz, 1H, H1), 4.37-4.13 (m, 2H, H6, H4), 4.02-3.97 (dd, J= 5.5/12.2 Hz, 1H, H6’), 3.74-3.43 (m, 
7H, 2xOCH2, OCH2CH2CN, H5), 3.40-3.28 (m, 2H, 2xCHisopropyl), 2.43-2.37 (m, 2H, CH2CN), 
1.87, 1.83, 1.80 (3s, 9H, 3 x OCOCH3), 0.95, 0.93 (m, 12H,  4CH3isopropyl);  13C NMR (75 MHz, 
CDCl3): δ = 170.4, 169.8, 169.3 (CO), 117.7 (CN), 101.6 (C1), 86.6 (d, JC,F = 186.7 Hz, C4), 72.4 
(d, JC,F = 19.5 Hz, C3), 71.2 (d, JC,F = 11.1 Hz, C5), 70.9 (d, JC,F = 4.35 Hz, C2), 69.5, 62.3 (CH2), 
61.9 (C6), 58.3 (CH2), 42.9 (NCHisopropyl), 24.5, 24.4 (CH3isopropyl), 20.6, 20.3 (OCCH3), 20.2 
(CH2CN). HRMS (FAB+) Calcd. for C23H38N2O10FNaP: (M+Na) 575.2146, found; 575.2164. 
2-(2,3,4-tri-O-acetyl-6-deoxy-6-fluoro-b-D-glucopyranosyloxy)ethyl (2-cyanoethyl) (N,N-
diisopropyl) phosphoramidite (53). 2-Hydroxyethyl 2,3,4-tri-O-acetyl-6-deoxy-6-fluoro-b-D-
glucopyranose 52 (0.150 g, 0.42 mmol) was reacted following the general procedure. The crude 
was purified by silica gel column chromathography (hexane:ethyl acetate, from 3:2 to 1:1 with 
1% NEt3) to give compound 53 as a syrup (150 mg, 65%); 1H NMR (500 MHz, CDCl3) δ ppm: 
5.08 (td, J= 3.0/9.5 Hz, 1H, H3), 5.05 (t, J= 9.5 Hz, 1H, H4), 5.00-4.97 (m, 1H, H2), 4.66 (dd, J= 
8.0/12.0 Hz, 1H, H1),  4.40-4.22 (dm, JH,F= 47.0 Hz, 2H, H6, H6’), 4.00-3.69 (m, 7H, 2xOCH2, 
OCH2CH2CN, H5), 3.64-3.57 (m, 2H, 2xCHisopropyl), 2.67-2.63 (m, 2H, CH2CN), 2.08, 2.06, 2.02 
(3 x OCOCH3), 1.19 (t, 12H,  4CH3isopropyl); 13C NMR (125 MHz, CDCl3): δ = 170.3, 169.5, 
169.3 (CO), 118.0 (CN), 100.9 (C1), 81.1 (d, JC,F = 174.0 Hz, C6), 72.7 (d, JC,F = 4.3 Hz, C3), 
72.5 (d, JC,F = 19.6 Hz, C5), 71.2 (C2), 69.4 (CH2), 68.1 (d, JC,F = 6.75 Hz, C4), 62.4, 58.5 (CH2), 
43.3 (NCHisopropyl), 24.6, 24.5 (CH3isopropyl), 20.7, 20.6 (OCCH3), 20.4 (CH2CN). HRMS (FAB+) 
Calcd. for C23H38N2O10FNaP: (M+Na) 575.2146, found; 575.2117.  
2-(2,3,6-tri-O-acetyl-4-deoxy-4-fluoro-b-D-galactopyranosyloxy)ethyl (2-cyanoethyl) (N,N-
diisopropyl) phosphoramidite (56). 2-Hydroxyethyl 2,3,6-tri-O-acetyl-4-deoxy-4-fluoro-b-D-
galactopyranose 55 (0.120 g, 0.34 mmol) was reacted following the general procedure. The crude 
was purified by silica gel column chromathography (hexane:ethyl acetate, 1:1 with 1% NEt3) to 
give compound 56 as a syrup (121 mg, 64%); 1H NMR (400 MHz, CDCl3) δ ppm: 5.25-5.22 (m, 
1H, H2), 5.01-4.90 (m, 1H, H3),  4.83 (d, J= 50.4 Hz, 1H, H4), 4.60 (dd, J= 8.0/11.8 Hz, 1H, H1), 
4.37-4.32 (m, 1H, H5), 4.23-4.18 (dd, J= 6.8/11.3 Hz, 1H, H6), 3.96-3.70 (m, 7H, 2xOCH2, 
OCH2CH2CN, H6’), 3.62-3.54 (m, 2H, 2xCHisopropyl), 2.66-2.62 (m, 2H, CH2CN), 2.1, 2.08, 2.06 
(3s, 9H, 3 x OCOCH3), 1.17 (t, J =6.6 Hz, 12H,  4xCH3isopropyl);  13C NMR (100 MHz, CDCl3): δ 
= 170.4, 170.3, 169.3 (CO), 117.7 (CN), 100.9 (C1), 85.8 (dd, JC,P = 6.8 Hz, JC,F = 185.1 Hz, C4), 
71.3 (dd, J = 4.7 Hz, J = 19.5 Hz), 70.8 (d, J = 18.0 Hz), 69.1 (dd, J = 25.2, 7.37  Hz), 68.6 (d, J 
= 4.8 Hz), 62.5 (dd, J = 7.7, 16.6  Hz), 61.3, 58.4 (d, J = 19.0 Hz, CH2), 42.9 (dd, J = 4.2, 12.39  
Hz, NCHisopropyl), 24.5, 24.4 (CH3isopropyl), 20.6, 20.3 (OCCH3), 20.2 (CH2CN). 19F NMR (CDCl3, 
323.6 MHz, internal reference TFT): -216.1 ppm. MS (ESI+) Calcd. for C23H38N2FO10NaP: 
(M+Na) 575.2146, found; 575.2248. 
2-(2,3-di-O-acetyl-4,6-dideoxy-4,6-difluoro-b-D-galactopyranosyloxy)ethyl (2-cyanoethyl) (N,N-
diisopropyl) phosphoramidite (59). 2-Hydroxyethyl 2,3-di-O-acetyl-4,6-dideoxy-4,6-difluoro-b-
D-galactopyranose 58 (0.120 g, 0.38 mmol) was reacted following the general procedure. The 
crude was purified by silica gel column chromathography (hexane:ethyl acetate, 1:1 with 1% 
NEt3) to give compound 59 as a syrup (125 mg, 62%); 1H NMR (400 MHz, CDCl3) δ ppm: 5.23-
5.21 (m, 1H, H2), 5.00-4.93 (m, 1H, H3),  4.86 (d, J= 50.4 Hz, 1H, H4), 4.62-4.52 (m, 3H, H6, H1, 
H6’), 3.97-3.65 (m, 7H, H5, 2xOCH2, OCH2CH2CN), 3.63-3.53 (m, 2H, 2xCHisopropyl), 2.66-2.61 
(m, 2H, CH2CN), 2.09-2.07 (m, 6H, 2xOCOCH3), 1.20 (t, J =6.6 Hz, 12H,  4CH3isopropyl);  13C 
NMR (100 MHz, CDCl3): δ = 170.3, 169.3 (CO), 117.9 (CN), 100.9 (C1), 85.7 (dd, J= 5.0 Hz, 
186 Hz, C4), 71.3 (dd, J = 4.7, 19.5 Hz, C6), 71.6, 71.4, 71.3, 71.2, 69.3, 68.2, 62.5, 58.4 (d, J = 
19.6 Hz, CH2), 42.9 (NCHisopropyl), 24.6, 24.5 (CH3isopropyl), 20.8, 20.7 (OCCH3), 20.3 (CH2CN). 
19F NMR (CDCl3, 323.6 MHz, internal reference TFT): -217.1, -231.0 ppm. MS (ESI+) Calcd. for 
C21H35N2O8F2NaP: (M+Na) 535.1997, found; 535.2005. 
 
Thermodynamic measurements. Melting curves for the DNA conjugates were measured in a 
Perkin–Elmer Lambda 750 UV/Vis spectrophotometer at 280 nm while the temperature was 
raised from 10 to 80 ºC at a rate of 1.0 ºCmin-1. Curve fits were excellent, with c2 values of 106 or 
better, and the Van’t Hoff linear fits were quite good (r2=0.98) for all oligonucleotides. DH, DS, 
and DG errors were calculated as described previously.4a,20 
NMR spectroscopy. Samples of all the conjugates were purified by HPLC, ion-exchanged with 
Dowex 50W resin and then suspended in 500 µL of either D2O or H2O/D2O 9:1 in phosphate 
buffer, 100 mM NaCl, pH 7. NMR spectra were acquired in Bruker Avance spectrometers 
operating at 600 or 800 MHz, and processed with Topspin software. DQF-COSY, TOCSY and 
NOESY experiments were recorded in D2O. The NOESY spectra were acquired with mixing 
times of 150 and 300 ms, and the TOCSY spectra were recorded with standard MLEV-17 
spin-lock sequence, and 80-ms mixing time. NOESY spectra in H2O were acquired with 100 ms 
mixing time. In 2D experiments in H2O, water suppression was achieved by including a 
WATERGATE23 module in the pulse sequence prior to acquisition. Two-dimensional 
experiments in D2O were carried out at temperatures ranging from 5 ºC to 25 ºC, whereas spectra 
in H2O were recorded at 5 ºC to reduce the exchange with water. The spectral analysis program 
Sparky24 was used for semiautomatic assignment of the NOESY cross-peaks and quantitative 
evaluation of the NOE intensities.  
Conjugate modeling and buried surface area calculations. Computer models of conjugates 9 
to 12 were built from the solution structure of the permethylated conjugate 12 determined in a 
previous study.13 The computer package Sybyl was used to perform the adequate –CH3 to –OH 
substitutions. The coordinates were energy minimized before surface area calculations. Models of 
the “open” conjugates were built by manually changing the torsion angles of the linking 
phosphate to locate the carbohydrate in a position where it is completely exposed to the solvent. 
The buried surface area is obtained as the difference between de surface area of the “open” and 
the “folded” model of the corresponding conjugate. Surface areas were calculated with the 
program MOLMOL.25 
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carbohydrate oligonucleotide conjugates (COCs) 5-17. Examples of melting and Van’t Hoff 
curves of the COCs. NMR proton assignments, relevant NOE’s and chemical shift changes for 
conjugates 13-17.  
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